Pros
You work with colleagues around you who are generally supportive, and work life balance is great. Overtime generally does not exist, and when it does, there is some compensation. The office is dog-friendly, and there's catered lunch on Fridays. The general colleagues you work with are almost like a family and are generally very kind.
Cons
Compensation is on the low end of the spectrum, especially when you factor in things like benefits (EI payments are only topped up by $357/week for the first sixteen weeks only, for example), or even the laptops we work on, which are the lowest-end 13'' MacBook Pro. We have lost productivity because our development machines are insufficient. We also haven't seen any raises in the last year and a half, and while I don't expect a 20% increase, I would at least think one just for inflation is more than a reasonable ask. My supervisor has no idea why his requests for salary adjustments have been muted. Several within the department have long deserved promotions and how to get to the next level has been unclear from high up. There was a change of guard two months ago. Before the change of regime, working in R&D, to say the least, was pretty bad. There was a lot of toxicity and finger-pointing, and some people left due to that situation. There was also one round of layoffs due to a missed sales quarter. The new regime came in. Since then, a second round of layoffs occured, and turnover has also greatly increased, with 2-3 people leaving most weeks since. Half of the executives have either been let go or have, well left. Some were critical and their work effectively went unnoticed, which we now have to backfill. This has been causing a major pain point for us at the moment. Our overall headcount is now almost 30% below our headcount just in January alone. Much of the said family earlier is gone. Moreover, part of the second round of layoffs was supposedly to free up additional cash to invest in R&D, with insistence we hire developers from India, but there has been very little communication about our direction and the next steps with respect to that and supposedly even the highest-up in R&D don't really know what's going on.